The purpose of the Hormone/Metabolite Core Laboratory is to make available to DERC investigators a variety of analytical techniques that are of interest in the study of diabetes, atherosclerosis, obesity, insulin resistance and related problems. The services provided are best based in a Core Laboratory because they require special instrumentation and methodology which would be difficult or impractically expensive to establish in the laboratories of the individual investigators who are Users of the DERC. The Hormone/Metabolite Core Laboratory has been in operation since 1980 as part of the New York Obesity Research Center (DERC). We now propose to broaden the research base ofthis Core by making it available to the Columbia University DERC. To this end, additional personnel are requested. In addition to being financially and technically expedient, the incorporation of the hormone/metabolite core in the DERC will facilitate scientific interactions between the diabetes research community in the Health Sciences campus and the New York Obesity Research Center at St. Luke's-Roosevelt Medical Center, an affiliated Hospital of Columbia University. The closer association has been encouraged by the leadership of Columbia University as a way of coordinating scientific efforts, while maximizing utilization of existing resources and reducing the need for additional facilities, an expensive commodity in Manhattan. The record of this core as part of the NYORC suggests that it will be an important asset of the Columbia DERC.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
1P30DK063608-01
Application #
6612245
Study Section
Special Emphasis Panel (ZDK1-GRB-7 (O1))
Project Start
2002-09-01
Project End
2007-08-31
Budget Start
Budget End
2004-01-31
Support Year
1
Fiscal Year
2003
Total Cost
$95,100
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Proto, Jonathan D; Doran, Amanda C; Subramanian, Manikandan et al. (2018) Hypercholesterolemia induces T cell expansion in humanized immune mice. J Clin Invest 128:2370-2375
Martin Carli, Jayne F; LeDuc, Charles A; Zhang, Yiying et al. (2018) FTO mediates cell-autonomous effects on adipogenesis and adipocyte lipid content by regulating gene expression via 6mA DNA modifications. J Lipid Res 59:1446-1460
Arnes, Luis; Liu, Zhaoqi; Wang, Jiguang et al. (2018) Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma. Gut :
Tamucci, Kirstin A; Namwanje, Maria; Fan, Lihong et al. (2018) The dark side of browning. Protein Cell 9:152-163
Accili, Domenico (2018) Insulin Action Research and the Future of Diabetes Treatment: The 2017 Banting Medal for Scientific Achievement Lecture. Diabetes 67:1701-1709
Ravussin, Yann; Edwin, Ethan; Gallop, Molly et al. (2018) Evidence for a Non-leptin System that Defends against Weight Gain in Overfeeding. Cell Metab 28:289-299.e5
Sui, Lina; Danzl, Nichole; Campbell, Sean R et al. (2018) ?-Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells. Diabetes 67:26-35
Laferrère, Blandine; Pattou, François (2018) Weight-Independent Mechanisms of Glucose Control After Roux-en-Y Gastric Bypass. Front Endocrinol (Lausanne) 9:530
Shah, Ankit; Levesque, Kiarra; Pierini, Esmeralda et al. (2018) Effect of sitagliptin on glucose control in type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery. Diabetes Obes Metab 20:1018-1023
Haeusler, Rebecca A; McGraw, Timothy E; Accili, Domenico (2018) Biochemical and cellular properties of insulin receptor signalling. Nat Rev Mol Cell Biol 19:31-44

Showing the most recent 10 out of 225 publications